GleamWall
中文EN

BGM BGM Group Ltd. Annual reports only

Pharmaceutical Preparations · Nasdaq · SEC CIK 1779578 · Fiscal year ends 09/30

Financial factors as of 2025-09-30 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY51.1%
TTM net income YoY-1,282.1%
TTM EPS YoY10.0%
Revenue 3-yr CAGR-16.4%
Net income 3-yr CAGR—

Margins

Gross margin16.6%
Operating margin-33.2%
Net margin-52.6%
FCF margin-10.4%
EBITDA margin-29.3%

Returns

ROE-9.2%
ROA-8.2%
ROIC (approx.)-4.8%
Asset turnover0.16x

Leverage & solvency

Liabilities / assets9.7%
Debt / equity0.00x
Current ratio1.24x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.12x
Accruals ratio-7.2%
Payout ratio—
Capex / revenue4.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-09-30FY20242024-09-30
Income statement
Revenue$37.92M$25.10M
Cost of revenue$31.61M$20.98M
Gross profit$6.31M$4.11M
R&D expense$672,669$1.36M
SG&A expense$18.22M$3.32M
Operating income-$12.58M-$563,771
Pretax income-$19.94M-$2.14M
Income tax$277,790-$619,981
Net income-$19.94M-$1.44M
EBITDA-$11.12M$673,458
EPS (basic)-0.18-0.20
EPS (diluted)-0.18-0.20
Weighted avg. shares (diluted)113.26M7.23M
Balance sheet
Cash & equivalents$9.82M$9.82M
Receivables$4.25M$1.54M
Inventory$20.10M$5.05M
Current assets$51.55M$29.77M
Goodwill$350.85M—
Intangibles$4.49M$4.54M
Total assets$433.81M$53.00M
Current liabilities$41.60M$8.78M
Total liabilities$41.92M$8.91M
Shareholders' equity$390.88M$42.74M
Shares outstanding200.62M7.23M
Cash flow statement
Operating cash flow-$2.37M$544,238
Capital expenditure$1.57M$240,133
Free cash flow-$3.94M$304,105
Investing cash flow-$162,908$983,418
Financing cash flow$2.62M-$491,728
Depreciation & amortization$1.46M$1.24M
Stock-based compensation$10.23M—

Free plan shows the latest 2 periods; Pro shows all 8 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.